Renaissance Technologies - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 228 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,943
-45.3%
68,082
-13.5%
0.02%
-34.6%
Q2 2023$18,176
-57.2%
78,682
-55.1%
0.03%
-53.6%
Q1 2023$42,488
+3094.6%
175,382
+3727.6%
0.06%
+2700.0%
Q4 2022$1,330
-99.7%
4,582
-4.5%
0.00%
+100.0%
Q1 2022$471,000
+132.0%
4,800
+100.0%
0.00%
Q4 2021$203,000
-85.1%
2,400
-86.0%
0.00%
-100.0%
Q3 2021$1,365,000
-73.6%
17,111
-67.7%
0.00%
-66.7%
Q2 2021$5,161,000
+28.7%
52,982
+54.5%
0.01%
+20.0%
Q1 2021$4,010,000
+6.0%
34,282
+0.7%
0.01%
+25.0%
Q4 2020$3,783,000
+46.3%
34,033
+56.2%
0.00%
+33.3%
Q3 2020$2,586,000
-68.5%
21,782
-69.9%
0.00%
-57.1%
Q2 2020$8,197,000
+363.6%
72,382
+173.3%
0.01%
+250.0%
Q1 2020$1,768,000
-78.0%
26,482
-69.8%
0.00%
-77.8%
Q4 2017$8,040,000
+40.4%
87,587
-31.2%
0.01%
+28.6%
Q3 2017$5,725,000
+367.0%
127,287
+68.8%
0.01%
+250.0%
Q2 2017$1,226,000
+37.6%
75,387
+30.3%
0.00%
+100.0%
Q1 2017$891,000
+4.1%
57,875
+0.7%
0.00%0.0%
Q4 2016$856,000
+27.4%
57,475
+8.5%
0.00%0.0%
Q3 2016$672,00052,9870.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$11,3428.78%
University of Wisconsin Foundation 40,133$5,861,0236.72%
Paulson & Co. 500,000$73,020,0006.53%
TCG Crossover Management, LLC 179,917$26,275,0793.87%
Avoro Capital Advisors LLC 1,555,000$227,092,2003.54%
Affinity Asset Advisors, LLC 85,000$12,413,4003.49%
Ghost Tree Capital, LLC 57,500$8,397,3002.76%
Lynwood Capital Management Inc. 5,000$730,2001.92%
MPM BioImpact LLC 40,859$5,967,0481.59%
Tri Locum Partners LP 33,761$4,930,4561.58%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders